Vaccines, virucides and drugs against HIV/AIDS: Hopes and optimisms for the future

A. A. Al-Jabri, F. Q. Alenzi

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

More than 25 million lives have been claimed by AIDS and 33.2 million people are estimated to have HIV, the majority of which are living in the underdeveloped countries. Failed tests on vaccines, virucides and complete virus eradication have caused scientists to refocus on the basic questions of what makes an effective HIV immune response. The "gloom" over disappointing research results on vaccine development and virucides "threatens to overshadow more positive" HIV/AIDS-related news, such as findings that male circumcision might reduce the likelihood of HIV transmission and that giving antiretroviral drugs to "high-risk" HIV-negative people (pre-exposure prophylaxis) could help protect them from infection. Something like pre-exposure prophylaxis has a good chance of becoming available before we have a 100% efficacious vaccine. The future in the field of HIV/AIDS will be much brighter if global research is appropriately coordinated and sufficient funds are available.

Original languageEnglish
Pages (from-to)1-3
Number of pages3
JournalOpen AIDS Journal
Volume3
DOIs
Publication statusPublished - 2009

Fingerprint

Acquired Immunodeficiency Syndrome
Vaccines
HIV
Pharmaceutical Preparations
Male Circumcision
Financial Management
Research
Viruses
Infection
Pre-Exposure Prophylaxis

Keywords

  • AIDS
  • Drugs
  • HIV
  • Immune response
  • Vaccines
  • Virucides

ASJC Scopus subject areas

  • Virology
  • Infectious Diseases
  • Public Health, Environmental and Occupational Health

Cite this

Vaccines, virucides and drugs against HIV/AIDS : Hopes and optimisms for the future. / Al-Jabri, A. A.; Alenzi, F. Q.

In: Open AIDS Journal, Vol. 3, 2009, p. 1-3.

Research output: Contribution to journalArticle

@article{3be290afa56846b791fbcc457ba72d46,
title = "Vaccines, virucides and drugs against HIV/AIDS: Hopes and optimisms for the future",
abstract = "More than 25 million lives have been claimed by AIDS and 33.2 million people are estimated to have HIV, the majority of which are living in the underdeveloped countries. Failed tests on vaccines, virucides and complete virus eradication have caused scientists to refocus on the basic questions of what makes an effective HIV immune response. The {"}gloom{"} over disappointing research results on vaccine development and virucides {"}threatens to overshadow more positive{"} HIV/AIDS-related news, such as findings that male circumcision might reduce the likelihood of HIV transmission and that giving antiretroviral drugs to {"}high-risk{"} HIV-negative people (pre-exposure prophylaxis) could help protect them from infection. Something like pre-exposure prophylaxis has a good chance of becoming available before we have a 100{\%} efficacious vaccine. The future in the field of HIV/AIDS will be much brighter if global research is appropriately coordinated and sufficient funds are available.",
keywords = "AIDS, Drugs, HIV, Immune response, Vaccines, Virucides",
author = "Al-Jabri, {A. A.} and Alenzi, {F. Q.}",
year = "2009",
doi = "10.2174/1874613600903010001",
language = "English",
volume = "3",
pages = "1--3",
journal = "Open AIDS Journal",
issn = "1874-6136",
publisher = "Bentham Science Publishers B.V.",

}

TY - JOUR

T1 - Vaccines, virucides and drugs against HIV/AIDS

T2 - Hopes and optimisms for the future

AU - Al-Jabri, A. A.

AU - Alenzi, F. Q.

PY - 2009

Y1 - 2009

N2 - More than 25 million lives have been claimed by AIDS and 33.2 million people are estimated to have HIV, the majority of which are living in the underdeveloped countries. Failed tests on vaccines, virucides and complete virus eradication have caused scientists to refocus on the basic questions of what makes an effective HIV immune response. The "gloom" over disappointing research results on vaccine development and virucides "threatens to overshadow more positive" HIV/AIDS-related news, such as findings that male circumcision might reduce the likelihood of HIV transmission and that giving antiretroviral drugs to "high-risk" HIV-negative people (pre-exposure prophylaxis) could help protect them from infection. Something like pre-exposure prophylaxis has a good chance of becoming available before we have a 100% efficacious vaccine. The future in the field of HIV/AIDS will be much brighter if global research is appropriately coordinated and sufficient funds are available.

AB - More than 25 million lives have been claimed by AIDS and 33.2 million people are estimated to have HIV, the majority of which are living in the underdeveloped countries. Failed tests on vaccines, virucides and complete virus eradication have caused scientists to refocus on the basic questions of what makes an effective HIV immune response. The "gloom" over disappointing research results on vaccine development and virucides "threatens to overshadow more positive" HIV/AIDS-related news, such as findings that male circumcision might reduce the likelihood of HIV transmission and that giving antiretroviral drugs to "high-risk" HIV-negative people (pre-exposure prophylaxis) could help protect them from infection. Something like pre-exposure prophylaxis has a good chance of becoming available before we have a 100% efficacious vaccine. The future in the field of HIV/AIDS will be much brighter if global research is appropriately coordinated and sufficient funds are available.

KW - AIDS

KW - Drugs

KW - HIV

KW - Immune response

KW - Vaccines

KW - Virucides

UR - http://www.scopus.com/inward/record.url?scp=76749093205&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=76749093205&partnerID=8YFLogxK

U2 - 10.2174/1874613600903010001

DO - 10.2174/1874613600903010001

M3 - Article

C2 - 19274070

AN - SCOPUS:76749093205

VL - 3

SP - 1

EP - 3

JO - Open AIDS Journal

JF - Open AIDS Journal

SN - 1874-6136

ER -